+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell & Gene Therapy Market - Global Forecast 2025-2030- Product Image
Cell & Gene Therapy Market - Global Forecast 2025-2030- Product Image
Sale

Cell & Gene Therapy Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011240
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cell and gene therapy market is transforming how major healthcare stakeholders approach the treatment of genetic, metabolic, oncologic, and neurologic disorders. Rapid advances across bioengineering, regulatory frameworks, and commercialization strategies are accelerating the adoption of these innovative therapies worldwide, presenting new strategic opportunities and operational challenges for industry leaders.

Market Snapshot: Cell & Gene Therapy Market Overview

The Cell & Gene Therapy Market grew from USD 16.65 billion in 2024 to USD 19.47 billion in 2025. It is expected to continue growing at a CAGR of 19.45%, reaching USD 48.39 billion by 2030. Expansion is rooted in breakthrough technologies, increasing regulatory support, and the sector’s ability to address conditions that lack effective treatments.

Scope & Segmentation of the Cell and Gene Therapy Market

  • Therapy Types: Cell therapies including stem cell and T cell-based platforms, and gene therapies with both ex vivo and in vivo approaches.
  • Delivery Methods: Intramuscular and intravenous administration routes supporting diverse clinical strategies.
  • Therapeutic Areas: Targeting cardiovascular and metabolic diseases, a wide range of neurological disorders, multiple oncology indications, and ophthalmology applications.
  • Applications: Clinical deployment for prevention and treatment, alongside research and development uses.
  • End Users: Academic and research institutes, private labs, universities, and healthcare providers such as hospitals and clinics.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with market activity in the UK, Germany, France, and beyond), and Asia-Pacific (spanning China, India, Japan, and other key countries).
  • Technology and Innovation: Includes lentiviral and nonviral vectors, genome editing tools, and single-use bioreactor technologies.
  • Key Players: Strategic innovators and manufacturers such as AbbVie Inc., Amgen Inc., Novartis AG, Pfizer Inc., and others actively shaping advancements and commercialization.

Key Takeaways for Senior Decision-Makers

  • Cell and gene therapy platforms have progressed from experimental procedures to critical tools in the strategic portfolios of biopharmaceutical companies, driven by both clinical successes and evolving molecular approaches.
  • The engineering of next-generation vectors and automation of cell manufacturing have enhanced both efficiency and safety profiles, allowing broader application across patient populations and indications.
  • Regulatory climates are shifting globally, with adaptive review pathways and cross-border harmonization simplifying multi-country clinical trial set-up and approval processes.
  • Emerging decentralized clinical trial models and strategic site selection have enabled companies to overcome logistical barriers in global studies, particularly in response to complex trade environments.
  • Market leaders leverage manufacturing scale-up, patient support frameworks, and strategic partnerships to maintain timely delivery of therapies and ensure competitive differentiation.

Impact of United States Tariffs on Supply Chains and Market Entry

In 2025, new tariffs imposed by the United States on key materials and equipment for cell and gene therapy production introduced immediate supply chain pressures. These changes prompted manufacturers to re-evaluate sourcing, increase localization, and partner with suppliers in tariff-friendly regions. Higher costs and logistical hurdles affected how companies managed production, clinical materials distribution, and global commercialization efforts, especially as organizations sought to maintain inventory flexibility and secure patient access despite unpredictable operational landscapes.

Methodology & Data Sources

This report integrates primary interviews with industry executives, clinical specialists, and manufacturing experts. Secondary sources include peer-reviewed literature, regulatory publications, and patent reviews. Triangulation of data ensures consistency, while thematic analysis uncovers actionable trends across modalities, delivery routes, and geographic segments.

Why This Report Matters

  • Enables senior decision-makers to identify priority investment areas and anticipate technology adoption shifts across therapeutic markets.
  • Facilitates strategic responses to regulatory developments, supply chain risks, and evolving reimbursement frameworks within the cell and gene therapy sector.

Conclusion

The cell and gene therapy market is entering a phase defined by regulatory innovation, strategic collaboration, and sustained advances in manufacturing. Stakeholder alignment, operational resilience, and a focus on patient-centric outcomes will drive continued sector growth and opportunity.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of allogeneic CAR T-cell therapies targeting solid tumors through universal donor platforms
5.2. Integration of CRISPR-based gene editing in in vivo therapies for rare genetic disorders to improve safety and efficacy
5.3. Adoption of automated closed-system manufacturing to reduce costs and scale production of personalized cell therapies
5.4. Development of next-generation AAV vector platforms to enhance tissue specificity and decrease immunogenicity in gene therapies
5.5. Implementation of decentralized point-of-care manufacturing models for on-site production of autologous cell therapies
5.6. Emergence of multi-specific and armored CAR T-cell constructs to overcome tumor microenvironment immunosuppression
5.7. Strategic partnerships between biotech firms and CDMOs to accelerate clinical development and commercialization of cell therapies
5.8. Regulatory harmonization efforts to streamline global approval pathways and accelerate patient access to gene treatments
5.9. Application of artificial intelligence and digital twins for process analytics and optimization in cell therapy manufacturing
5.10. Investment in supply chain innovations, including cryopreservation and cold chain logistics, to ensure cell product viability worldwide
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cell & Gene Therapy Market, by Therapy Type
8.1. Introduction
8.2. Cell Therapy
8.2.1. Stem Cell Therapies
8.2.1.1. Hematopoietic Stem Cell Therapies
8.2.1.2. Mesenchymal Stem Cell Therapies
8.2.2. T Cell Therapy
8.2.2.1. CAR T Cell Therapy
8.2.2.2. T Cell Receptor (TCR)-based
8.3. Gene Therapy
8.3.1. Ex Vivo Gene Therapy
8.3.2. In Vivo Gene Therapy
9. Cell & Gene Therapy Market, by Delivery Method
9.1. Introduction
9.2. Intramuscular
9.3. Intravenous
10. Cell & Gene Therapy Market, by Therapeutic Areas
10.1. Introduction
10.2. Cardiovascular
10.2.1. Congestive Heart Failure
10.2.2. Ischemic Heart Disease
10.3. Metabolic Disorders
10.3.1. Diabetes
10.3.2. Obesity
10.4. Neurological Disorders
10.4.1. Alzheimer's Disease
10.4.2. Huntington's Disease
10.4.3. Multiple Sclerosis
10.4.4. Parkinson's Disease
10.4.5. Spinal Cord Injuries
10.5. Oncology
10.5.1. Hematological Malignancies
10.5.2. Lymphomas
10.5.3. Solid Tumors
10.6. Ophthalmology
11. Cell & Gene Therapy Market, by Application
11.1. Introduction
11.2. Clinical Applications
11.2.1. Disease Prevention
11.2.2. Disease Treatment
11.3. Research & Development
12. Cell & Gene Therapy Market, by End User
12.1. Introduction
12.2. Academic & Research Institutes
12.2.1. Private Research Labs
12.2.2. Universities
12.3. Hospitals & Clinics
13. Americas Cell & Gene Therapy Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cell & Gene Therapy Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cell & Gene Therapy Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AbbVie Inc.
16.3.2. Abeona Therapeutics Inc.
16.3.3. Adaptimmune Therapeutics PLC
16.3.4. AGC Inc.
16.3.5. Alnylam Pharmaceuticals, Inc.
16.3.6. American Gene Technologies Inc.
16.3.7. Amgen Inc.
16.3.8. AnGes, Inc
16.3.9. Astellas Pharma Inc.
16.3.10. Becton, Dickinson and Company
16.3.11. Biogen Inc.
16.3.12. Bluebird Bio, Inc.
16.3.13. BridgeBio Pharma, Inc.
16.3.14. Bristol-Myers Squibb Company
16.3.15. C.H. Boehringer Sohn AG & Co. KG
16.3.16. Cellectis SA
16.3.17. CRISPR Therapeutics AG
16.3.18. F. Hoffmann-La Roche AG
16.3.19. Gilead Sciences, Inc.
16.3.20. Intellia Therapeutics, Inc.
16.3.21. Ionis Pharmaceuticals, Inc.
16.3.22. Johnson & Johnson Services Inc.
16.3.23. Kyowa Kirin Co., Ltd.
16.3.24. Merck KGaA
16.3.25. Moderna, Inc.
16.3.26. Mustang Bio, Inc.
16.3.27. Novartis AG
16.3.28. Novo Nordisk A/S
16.3.29. Pfizer, Inc.
16.3.30. REGENXBIO Inc.
16.3.31. Sangamo Therapeutics, Inc.
16.3.32. Sarepta Therapeutics, Inc.
16.3.33. Shoreline Biosciences
16.3.34. Sibiono GeneTech Co. Ltd.
16.3.35. Syncona Limited
16.3.36. Thermo Fisher Scientific Inc.
16.3.37. Vertex Pharmaceuticals Incorporated
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CELL & GENE THERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CELL & GENE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CELL & GENE THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CELL & GENE THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CELL & GENE THERAPY MARKET: RESEARCHAI
FIGURE 26. CELL & GENE THERAPY MARKET: RESEARCHSTATISTICS
FIGURE 27. CELL & GENE THERAPY MARKET: RESEARCHCONTACTS
FIGURE 28. CELL & GENE THERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CELL & GENE THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CELL & GENE THERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CELL & GENE THERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CAR T CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CAR T CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY T CELL RECEPTOR (TCR)-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY T CELL RECEPTOR (TCR)-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY EX VIVO GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY EX VIVO GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY IN VIVO GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY IN VIVO GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ISCHEMIC HEART DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ISCHEMIC HEART DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY OBESITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY OBESITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HUNTINGTON'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HUNTINGTON'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY SPINAL CORD INJURIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY SPINAL CORD INJURIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY LYMPHOMAS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY LYMPHOMAS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DISEASE TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DISEASE TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY PRIVATE RESEARCH LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY PRIVATE RESEARCH LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES CELL & GENE THERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 177. CANADA CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 178. CANADA CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 179. CANADA CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 180. CANADA CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 181. CANADA CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 182. CANADA CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 183. CANADA CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 184. CANADA CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 185. CANADA CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 186. CANADA CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 187. CANADA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 188. CANADA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 189. CANADA CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 190. CANADA CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 191. CANADA CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 192. CANADA CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 193. CANADA CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 194. CANADA CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 195. CANADA CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 196. CANADA CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 197. CANADA CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 198. CANADA CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 199. CANADA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. CANADA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. CANADA CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 202. CANADA CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 203. CANADA CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. CANADA CELL & GENE THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. CANADA CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 206. CANADA CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 207. MEXICO CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 208. MEXICO CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 209. MEXICO CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 210. MEXICO CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 211. MEXICO CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 212. MEXICO CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 213. MEXICO CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 214. MEXICO CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 215. MEXICO CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 216. MEXICO CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 217. MEXICO CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 218. MEXICO CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 219. MEXICO CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 220. MEXICO CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 221. MEXICO CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 222. MEXICO CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 223. MEXICO CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 224. MEXICO CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 225. MEXICO CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 226. MEXICO CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 227. MEXICO CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 228. MEXICO CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 229. MEXICO CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. MEXICO CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. MEXICO CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 232. MEXICO CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 233. MEXICO CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. MEXICO CELL & GENE THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. MEXICO CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 236. MEXICO CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cell & Gene Therapy market report include:
  • AbbVie Inc.
  • Abeona Therapeutics Inc.
  • Adaptimmune Therapeutics PLC
  • AGC Inc.
  • Alnylam Pharmaceuticals, Inc.
  • American Gene Technologies Inc.
  • Amgen Inc.
  • AnGes, Inc
  • Astellas Pharma Inc.
  • Becton, Dickinson and Company
  • Biogen Inc.
  • Bluebird Bio, Inc.
  • BridgeBio Pharma, Inc.
  • Bristol-Myers Squibb Company
  • C.H. Boehringer Sohn AG & Co. KG
  • Cellectis SA
  • CRISPR Therapeutics AG
  • F. Hoffmann-La Roche AG
  • Gilead Sciences, Inc.
  • Intellia Therapeutics, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Johnson & Johnson Services Inc.
  • Kyowa Kirin Co., Ltd.
  • Merck KGaA
  • Moderna, Inc.
  • Mustang Bio, Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • REGENXBIO Inc.
  • Sangamo Therapeutics, Inc.
  • Sarepta Therapeutics, Inc.
  • Shoreline Biosciences
  • Sibiono GeneTech Co. Ltd.
  • Syncona Limited
  • Thermo Fisher Scientific Inc.
  • Vertex Pharmaceuticals Incorporated

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 19.47 Billion
Forecasted Market Value ( USD ) by 2030 $ 48.39 Billion
Compound Annual Growth Rate19.4%
Regions CoveredGlobal
No. of Companies Mentioned38

Related Topics

Related Reports

Cell & Gene Therapy Clinical Trials Market - Global Forecast 2025-2030 - Product Image

Cell & Gene Therapy Clinical Trials Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Personalized Nanotechnology for Cell & Gene Therapies Market - Global Forecast 2025-2030 - Product Image

Personalized Nanotechnology for Cell & Gene Therapies Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Cell and Gene Therapy Bioanalytical Testing Services Market Size, Share & Trends Analysis Report by Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics), Stage of Development, Product Type, Indication, and Region with Growth Forecasts, 2025-2030 - Product Image

Cell and Gene Therapy Bioanalytical Testing Services Market Size, Share & Trends Analysis Report by Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics), Stage of Development, Product Type, Indication, and Region with Growth Forecasts, 2025-2030

  • Report
  • 261 Pages
  • Global
From
Cell and Gene Therapy Third-Party Logistics Market Size, Share & Trends Analysis Report by Type (Clinical), Product (Cell Therapies, Gene Therapies), Temperature Range (Ambient Storage), Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Cell and Gene Therapy Third-Party Logistics Market Size, Share & Trends Analysis Report by Type (Clinical), Product (Cell Therapies, Gene Therapies), Temperature Range (Ambient Storage), Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Gene Therapy Market Size, Share, Trends and Forecast by Gene Type, Vector Type, Delivery Method, Application, and Region, 2025-2033 - Product Image

Gene Therapy Market Size, Share, Trends and Forecast by Gene Type, Vector Type, Delivery Method, Application, and Region, 2025-2033

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.